Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Elicera Therapeutics AB (DE:8E8)

FRANKFURT:8E8

8E8

Elicera Therapeutics AB

RESEARCH TOOLSreports

Elicera Therapeutics AB (8E8) Ratios

Compare

0 Followers

Elicera Therapeutics AB Ratios

DE:8E8's free cash flow for Q4 2025 was kr0.00. For the 2025 fiscal year, DE:8E8's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	6.75	6.75	4.06	2.19	3.39
Quick Ratio	6.75	6.75	4.06	2.19	3.27
Cash Ratio	6.12	6.12	3.89	2.13	3.24
Solvency Ratio	-4.29	-4.29	-2.37	-1.19	-1.44
Operating Cash Flow Ratio	-5.31	-5.31	-3.45	-1.08	-0.63
Short-Term Operating Cash Flow Coverage	0.00	0.00	0.00	0.00	0.00
Net Current Asset Value	kr 23.35M	kr 23.35M	kr 20.77M	kr 16.39M	kr 32.29M
Leverage Ratios
Debt-to-Assets Ratio	0.00	0.00	0.00	0.00	0.00
Debt-to-Equity Ratio	0.00	0.00	0.00	0.00	0.00
Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.17	1.17	1.33	1.84	1.41
Debt Service Coverage Ratio	-1.91K	-2.21K	0.00	0.00	-150.20
Interest Coverage Ratio	-1.95K	-2.28K	0.00	0.00	-149.71
Debt to Market Cap	0.00	0.00	0.00	0.00	0.00
Interest Debt Per Share	<0.01	<0.01	0.00	0.00	<0.01
Net Debt to EBITDA	1.41	1.43	1.57	1.72	2.26
Profitability Margins
Gross Profit Margin	100.00%	0.00%	100.00%	99.89%	100.01%
EBIT Margin	-604.12%	0.00%	-236.87%	-152.24%	-1518.67%
EBITDA Margin	-603.92%	0.00%	-236.00%	-152.14%	-1517.73%
Operating Profit Margin	-615.57%	0.00%	-236.87%	-252.24%	-1512.73%
Pretax Profit Margin	-597.11%	0.00%	-226.01%	-146.02%	-1518.67%
Net Profit Margin	-597.11%	0.00%	-226.01%	-146.02%	-1524.61%
Continuous Operations Profit Margin	-597.11%	0.00%	-226.01%	-146.02%	-1518.67%
Net Income Per EBT	100.00%	100.00%	100.00%	100.00%	100.39%
EBT Per EBIT	97.00%	97.00%	95.42%	57.89%	100.39%
Return on Assets (ROA)	-63.48%	-63.48%	-58.45%	-54.33%	-42.14%
Return on Equity (ROE)	-59.78%	-74.51%	-77.56%	-99.98%	-59.50%
Return on Capital Employed (ROCE)	-76.81%	-76.81%	-81.29%	-172.71%	-59.03%
Return on Invested Capital (ROIC)	-76.81%	-76.81%	-81.29%	-172.71%	-59.03%
Return on Tangible Assets	-63.48%	-63.48%	-58.45%	-54.36%	-42.16%
Earnings Yield	-6.77%	-7.32%	-30.56%	-17.16%	-28.07%
Efficiency Ratios
Receivables Turnover	1.13	0.00	8.08	33.29	3.87
Payables Turnover	0.00	0.00	0.00	0.00	0.02
Inventory Turnover	0.00	0.00	0.00	0.00	<0.01
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00
Asset Turnover	0.11	0.00	0.26	0.37	0.03
Working Capital Turnover Ratio	0.11	0.00	0.38	0.46	0.03
Cash Conversion Cycle	322.42	0.00	45.16	10.96	28.47K
Days of Sales Outstanding	322.42	0.00	45.16	10.96	94.26
Days of Inventory Outstanding	0.00	0.00	0.00	0.00	51.06K
Days of Payables Outstanding	0.00	0.00	0.00	0.00	22.69K
Operating Cycle	322.42	0.00	45.16	10.96	51.15K
Cash Flow Ratios
Operating Cash Flow Per Share	-0.44	-0.47	-0.74	-0.75	-0.43
Free Cash Flow Per Share	-0.44	-0.47	-0.74	-0.75	-0.43
CapEx Per Share	0.00	0.00	0.00	<0.01	0.00
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	0.00	0.00	0.00	-14.92K	0.00
Capital Expenditure Coverage Ratio	0.00	0.00	0.00	-14.92K	0.00
Operating Cash Flow Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	-7.39	0.00	-3.29	-1.33	-6.70
Free Cash Flow Yield	-8.38%	-9.06%	-44.50%	-15.62%	-12.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-14.78	-13.67	-3.27	-5.83	-3.56
Price-to-Sales (P/S) Ratio	88.24	0.00	7.40	8.51	54.32
Price-to-Book (P/B) Ratio	11.01	10.19	2.54	5.83	2.12
Price-to-Free Cash Flow (P/FCF) Ratio	-11.94	-11.04	-2.25	-6.40	-8.11
Price-to-Operating Cash Flow Ratio	-11.94	-11.04	-2.25	-6.40	-8.11
Price-to-Earnings Growth (PEG) Ratio	0.72	0.54	0.08	0.38	-0.18
Price-to-Fair Value	11.01	10.19	2.54	5.83	2.12
Enterprise Value Multiple	-13.20	-12.25	-1.56	-3.87	-1.32
Enterprise Value	232.39M	213.10M	26.32M	66.16M	25.71M
EV to EBITDA	-13.20	-12.25	-1.56	-3.87	-1.32
EV to Sales	79.72	0.00	3.69	5.89	20.09
EV to Free Cash Flow	-10.78	-9.89	-1.12	-4.43	-3.00
EV to Operating Cash Flow	-10.78	-9.89	-1.12	-4.43	-3.00
Tangible Book Value Per Share	0.48	0.51	0.66	0.83	1.66
Shareholders’ Equity Per Share	0.48	0.51	0.66	0.83	1.66
Tax and Other Ratios
Effective Tax Rate	0.00	0.00	0.00	0.00	0.00
Revenue Per Share	0.06	0.00	0.23	0.57	0.06
Net Income Per Share	-0.36	-0.38	-0.51	-0.83	-0.99
Tax Burden	1.00	1.00	1.00	1.00	1.00
Interest Burden	0.99	1.00	0.95	0.96	1.00
Research & Development to Revenue	0.00	0.00	0.00	0.00	0.00
SG&A to Revenue	0.00	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	1.20	1.20	1.42	0.91	0.44

Currency in SEK